MAPT and Alzheimer disease: There is still some controversy about the specificity of pyridoindole and arylquinoline ligands for non-AD tau, with conflicting findings reported in vivo and in vitro (Chiotis et al., 2016; Ishiki et al., 2016; Smith et al., 2016).